Shenzhen Weiguang Biological Products Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100002Q58
CNY
22.15
0.51 (2.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,260.81
1,197.58
1,044.12
664.82
902.99
898.31
815.15
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,260.81
1,197.58
1,044.12
664.82
902.99
898.31
815.15
Raw Material Cost
792.92
717.78
631.47
439.86
545.24
576.18
513.77
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
141.36
140.87
118.27
96.67
94.66
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
21.85
22.87
15.31
3.02
3.06
1.19
0.55
Selling and Distribution Expenses
145.64
118.79
115.35
85.28
84.50
74.62
76.11
Other Expenses
-13.15
-12.48
-7.78
-7.11
-5.30
4.15
3.69
Total Expenditure (Excl Depreciation)
970.24
875.53
802.59
553.76
674.45
693.53
627.32
Operating Profit (PBDIT) excl Other Income
290.59999999999997
322
241.5
111.1
228.5
204.8
187.8
Other Income
17.88
15.59
21.99
16.70
18.43
15.45
11.02
Operating Profit (PBDIT)
462.80
454.10
349.55
192.86
301.05
266.70
238.64
Interest
21.85
22.87
15.31
3.02
3.06
1.19
0.55
Exceptional Items
1.48
-14.05
0.66
14.33
0.42
0.00
0.00
Gross Profit (PBDT)
467.89
479.80
412.65
224.96
357.75
322.13
301.37
Depreciation
159.40
120.44
89.44
66.84
57.24
46.47
39.79
Profit Before Tax
283.02
296.74
245.45
137.32
241.17
219.04
198.29
Tax
37.23
42.78
27.91
16.10
36.18
29.46
27.14
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
246.32
253.52
218.65
117.52
205.44
190.40
171.34
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
246.32
253.52
218.65
117.52
205.44
190.40
171.34
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-0.53
0.44
-1.11
3.69
-0.44
-0.81
-0.19
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
245.79
253.96
217.54
121.21
204.99
189.59
171.15
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,412.39
2,211.43
2,014.28
1,840.99
1,768.73
1,603.79
1,447.95
Earnings per share (EPS)
1.09
1.12
0.96
0.52
0.91
0.84
0.76
Diluted Earnings per share
1.09
1.12
0.96
0.52
0.91
0.84
0.76
Operating Profit Margin (Excl OI)
22.65%
26.56%
22.81%
16.44%
24.96%
22.8%
23.04%
Gross Profit Margin
35.09%
34.84%
32.07%
30.71%
33.05%
29.56%
29.21%
PAT Margin
19.54%
21.17%
20.94%
17.68%
22.75%
21.2%
21.02%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 5.28% vs 14.70% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is -3.23% vs 16.78% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 1.46% vs 33.85% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is -4.80% vs 49.67% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has fallen from Dec 2024

Compare Annual Results Of Shenzhen Weiguang Biological Products Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,260.81
0
1,260.81
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,260.81
0
1,260.81
Raw Material Cost
792.92
0
792.92
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
141.36
0
141.36
Power Cost
0
0
0.00
Manufacturing Expenses
21.85
0
21.85
Selling and Distribution Expenses
145.64
0
145.64
Other Expenses
-13.15
0.00
-13.15
Total Expenditure (Excl Depreciation)
970.24
0
970.24
Operating Profit (PBDIT) excl Other Income
290.57
0.00
290.57
Other Income
17.88
0
17.88
Operating Profit (PBDIT)
462.80
0
462.80
Interest
21.85
0
21.85
Exceptional Items
1.48
0
1.48
Gross Profit (PBDT)
467.89
0
467.89
Depreciation
159.40
0
159.40
Profit Before Tax
283.02
0
283.02
Tax
37.23
0
37.23
Provisions and contingencies
0
0
0.00
Profit After Tax
246.32
0
246.32
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
246.32
0
246.32
Share in Profit of Associates
0
0
0.00
Minority Interest
-0.53
0
-0.53
Other related items
0.00
0.00
0.00
Consolidated Net Profit
245.79
0
245.79
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,412.39
0
2,412.39
Earnings per share (EPS)
1.09
0
1.09
Diluted Earnings per share
1.09
0
1.09
Operating Profit Margin (Excl OI)
22.65%
0%
0.00
22.65%
Gross Profit Margin
35.09%
0%
0.00
35.09%
PAT Margin
19.54%
0%
0.00
19.54%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 126.08 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 5.28% vs 14.70% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 24.58 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -3.23% vs 16.78% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 44.49 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 1.46% vs 33.85% in Dec 2024

Annual - Interest
Interest 2.18 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is -4.80% vs 49.67% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 22.65%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has fallen from Dec 2024